Company Data
Larimar Therapeutics Inc.
Ticker
LRMR
Current Price
$3.13 -3.99%
Market Cap
$267.9M
Price Target
Refer to Report
Volume
1.6M
52wk Range
$1.61 - $5.37
Overview
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich’s ataxia.